Literature DB >> 6323326

Induction of Epstein-Barr virus antigens by tumor promoters for epidermal and nonepidermal tissues.

K Takada, H Zur Hausen.   

Abstract

Fifteen established tumor promoters belonging to different chemical groups were tested for their ability to induce Epstein-Barr virus (EBV)-specific early antigens (EA) in EBV-genome-positive nonproducer Raji cells. Saccharin (a promoter in urinary bladder carcinogenesis), DDT (a promoter in liver carcinogenesis), anthralin and iodoacetic acid (promoters in skin carcinogenesis) gave a significant induction with a maximum of induced cells of 20% (8 mg/ml), 0.8% (20 micrograms/ml), 0.8% (100 ng/ml) and 0.7% (0.4 micrograms/ml), respectively. In addition, after combined application with a noninducing dose (0.2 ng/ml) of 12-O-tetradecanoyl-phorbol-13-acetate (TPA), seven additional tumor promoters induced 0.3-2.1% EA-positive cells two days after treatment. The results indicate that in addition to mouse skin tumor promoters such as diterpene esters, several compounds reported to possess tumor-promoting activity in other types of tissue induce EBV. The data suggest that EBV induction is an effect commonly exerted by this group of compounds which should be very useful in screening for environmental tumor promoters.

Entities:  

Mesh:

Substances:

Year:  1984        PMID: 6323326     DOI: 10.1002/ijc.2910330412

Source DB:  PubMed          Journal:  Int J Cancer        ISSN: 0020-7136            Impact factor:   7.396


  5 in total

1.  Both the rightward and the leftward open reading frames within the BamHI M DNA fragment of Epstein-Barr virus act as trans-activators of gene expression.

Authors:  M O Oguro; N Shimizu; Y Ono; K Takada
Journal:  J Virol       Date:  1987-10       Impact factor: 5.103

2.  trans activation of the latent Epstein-Barr virus (EBV) genome after transfection of the EBV DNA fragment.

Authors:  K Takada; N Shimizu; S Sakuma; Y Ono
Journal:  J Virol       Date:  1986-03       Impact factor: 5.103

3.  Induction of Epstein-Barr virus early antigens by tumor promoters of the diterpene ester type in Raji cells and specific (receptor) binding as compared to irritant and promoting activities.

Authors:  U Kloz; M Hergenhahn; M Fellhauer; E Hecker
Journal:  J Cancer Res Clin Oncol       Date:  1989       Impact factor: 4.553

4.  Analysis of the BZLF1 promoter of Epstein-Barr virus: identification of an anti-immunoglobulin response sequence.

Authors:  N Shimizu; K Takada
Journal:  J Virol       Date:  1993-06       Impact factor: 5.103

5.  Effects of S-adenosylhomocysteine and analogs on Epstein-Barr virus-induced transformation, expression of the Epstein-Barr virus capsid antigen, and methylation of Epstein-Barr virus DNA.

Authors:  W K Long; G E Fronko; R G Lindemeyer; B Wu; E E Henderson
Journal:  J Virol       Date:  1987-01       Impact factor: 5.103

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.